Submit Manuscript  

Article Details


Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options

[ Vol. 17 , Issue. 1 ]

Author(s):

Daniel Dejcman, Dirk Skowasch, Carmen Pizarro, Andreas Krause, Daniel Thomas and Valentin Sebastian Schäfer*   Pages 17 - 28 ( 12 )

Abstract:


Interstitial lung disease (ILD) is the most common form of pulmonary impairment in patients with rheumatoid arthritis (RA). However, patients with RA or other arthritic diseases such as psoriatic arthritis (PsA) or peripheral spondyloarthritis (pSpA) are at a higher risk of developing several other pulmonary diseases, such as chronic obstructive lung disease (COPD), compared to patients without arthritis. This review aims at summarizing the current knowledge on the prevalence of pulmonary diseases in the above-mentioned forms of arthritis, the challenges faced by prevalence studies in detecting pulmonary diseases in patients with arthritis, as well as possible treatment options. Dyspnea, cough or other pulmonary symptoms in arthritis patients should prompt gradual diagnostic procedures considering pulmonary manifestations as a major cluster of differential diagnosis. However, treatment options often lack solid evidence-based guidelines and referrals to specialized centers are often necessary.

Keywords:

Rheumatoid arthritis, psoriatic arthritis, peripheral spondyloarthritis, pulmonary manifestation, extra-articular manifestation, interstitial lung disease.

Affiliation:

Department of Internal Medicine III – Oncology, Hematology, Immunology and Rheumatology, University Hospital Bonn, Bonn, Department of Internal Medicine II – Cardiology, Angiology and Pulmonology, University Hospital Bonn, Bonn, Department of Internal Medicine II – Cardiology, Angiology and Pulmonology, University Hospital Bonn, Bonn, Rheumatology and Clinical Immunology, Immanuel Krankenhaus Berlin, Berlin, Department of Radiology, University Hospital Bonn, Bonn, Department of Internal Medicine III – Oncology, Hematology, Immunology and Rheumatology, University Hospital Bonn, Bonn

Graphical Abstract:



Read Full-Text article